Ali Iranmanesh

1. COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics
   2025/01/29 by Rajiv Agarwal, Jennifer B. Green, Hiddo J.L. Heerspink +96 · 1 voice · 2 citations
   Medicine · #Hormonal Regulation and Hypertension #Diabetes Treatment and Management #Parathyroid Disorders and Treatments